Vaccitech (VACC)
NASDAQ: VACC
· Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM
Vaccitech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 14.17M | 14.97M | n/a | n/a | 334K | 468K | 6.46M | 6.17M | 17.06M | 15.02M | -1K | 19K | 35K | 215K |
Cost of Revenue | n/a | -8.39M | n/a | n/a | n/a | 13.54M | 9.81M | 12.19M | 9.74M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 22.55M | n/a | n/a | n/a | -13.21M | -9.35M | -5.73M | -3.58M | 17.06M | 15.02M | -1K | 19K | 35K | 215K |
Operating Income | 329K | 65.1M | 210K | 577K | -16.11M | -26.34M | -21.48M | -26.04M | 7.55M | 13.79M | 654K | -16.67M | -5.54M | -16.84M | -6.17M |
Interest Income | 556K | 372K | 631K | 635K | 196K | 522K | 1.59M | 1.32M | 1.03M | 735K | 83K | n/a | n/a | n/a | 2K |
Pretax Income | -19.68M | -2.81M | -8.13M | -16.95M | -14.71M | -24.96M | -18.74M | -23.18M | 7.55M | 14.77M | 1.71M | -15.14M | -4.58M | -15.97M | -15.45M |
Net Income | -19.65M | -4.98M | -8.11M | -16.93M | -14.07M | -23.8M | -18.22M | -21.16M | 8.24M | 15.69M | 2.6M | -15.11M | -4.56M | -15.93M | -15.27M |
Selling & General & Admin | 12.64M | 3.44M | 13.42M | 7.2M | 961K | 13.13M | 12.14M | 20.31M | -11.13M | -6.45M | 3.66M | 9.79M | 1.18M | 12.37M | 1.78M |
Research & Development | 8.29M | 6.66M | 11.14M | 11.66M | 13.94M | 12.98M | 8.66M | 12.1M | 10.47M | 8.89M | 9.65M | 5.67M | 3.41M | 3.63M | 3.65M |
Other Expenses | n/a | n/a | n/a | n/a | -2K | 310K | n/a | 516K | n/a | n/a | n/a | n/a | n/a | -3K | n/a |
Operating Expenses | 20.93M | 10.1M | 24.56M | 18.86M | 14.9M | 26.11M | 20.8M | 32.4M | -664K | 2.45M | 13.32M | 15.46M | 4.6M | 16M | 5.43M |
Interest Expense | -13K | -74K | -17K | -12K | 7K | 14K | n/a | n/a | 1.03M | n/a | 74K | 18K | n/a | n/a | 2.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 1.71M | n/a | n/a | 14.9M | 26.11M | 20.8M | 32.4M | -664K | 2.45M | 13.32M | 15.46M | 4.6M | 16M | 5.43M |
Income Tax Expense | -32K | 2.1M | -18K | -19K | -603K | -1.14M | -516K | -2.02M | -674K | -915K | -863K | 32K | -7K | 12K | -65K |
Shares Outstanding (Basic) | 40.27M | 39.35M | 39.42M | 39.04M | 38.53M | 38.39M | 37.88M | 37.35M | 37.25M | 37.2M | 37.19M | 35.49M | 34.84M | 24.89M | 34.06M |
Shares Outstanding (Diluted) | 40.27M | 39.35M | 39.42M | 39.04M | 38.53M | 38.41M | 38.01M | 37.35M | 38.16M | 38.17M | 38.35M | 35.49M | 34.84M | 24.9M | 34.06M |
EPS (Basic) | -0.49 | -0.08 | -0.21 | -0.43 | -0.37 | -0.62 | -0.48 | -0.57 | 0.22 | 0.41 | 0.07 | -0.43 | -0.13 | -0.64 | -0.45 |
EPS (Diluted) | -0.49 | -0.08 | -0.21 | -0.43 | -0.37 | -0.62 | -0.48 | -0.57 | 0.22 | 0.41 | 0.07 | -0.43 | -0.13 | -0.64 | -0.45 |
EBITDA | 329K | -8.47M | 210K | 577K | -13.23M | -25.28M | -18.74M | -22.04M | 8.33M | 13.79M | 2.75M | -15.34M | -4.49M | -15.87M | -5.12M |
EBIT | n/a | 39.65M | n/a | n/a | -14.71M | -24.95M | -21.48M | -23.1M | 8.58M | n/a | 1.78M | -15.09M | n/a | n/a | -12.62M |
Depreciation & Amortization | n/a | -5.52M | n/a | n/a | 1.47M | 1.3M | 2.75M | 3.99M | 781K | 2.44M | 966K | 321K | 85K | 104K | 92K |